Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?
Alexandre Olivier GérardAudrey LaurainGuillaume FavreMilou-Daniel DriciVincent L M EsnaultPublished in: Diabetes care (2022)